Table 3.
HOMA-IR and HOMA-B levels according to anthropometric and blood chemistry tests in non-diabetic subjects
mean ± SD, (n = 5,492) | |||||
---|---|---|---|---|---|
Variables | Category | HOMA-IR | p value | HOMA-B | p value |
αWC (cm) | Males <90 or Females <80 | 2.13 ± 1.14 | <0.001 | 128.98 ± 63.26 | <0.001 |
Males ≥90 or Females ≥80 | 2.92 ± 1.46 | 140.54 ± 73.19 | |||
βBMI (kg/m2) | <25 | 2.14 ± 1.15 | <0.001 | 128.81 ± 68.04 | <0.001 |
≥25 | 2.96 ± 1.45 | 142.27 ± 73.52 | |||
γSBP (mmHg) | <140 | 2.38 ± 1.32 | 0.003 | 135.01 ± 71.79 | <0.001 |
≥140 | 2.55 ± 1.13 | 117.03 ± 54.89 | |||
δDBP (mmHg) | <90 | 2.37 ± 1.30 | <0.001 | 133.49 ± 71.19 | 0.126 |
≥90 | 2.65 ± 1.32 | 127.81 ± 58.81 | |||
εTC (mg/dl) | <200 | 2.37 ± 1.29 | <0.001 | 132.80 ± 65.57 | 0.185 |
≥200 | 2.75 ± 1.55 | 138.42 ± 83.80 | |||
ζTGs (mg/dl) | <150 | 2.22 ± 1.07 | <0.001 | 131.26 ± 65.76 | 0.002 |
≥150 | 2.86 ± 1.70 | 138.03 ± 81.40 | |||
ηHDL-C (mg/dl) | Males ≥40 or Females ≥50 | 2.22 ± 0.95 | <0.001 | 128.03 ± 57.94 | <0.001 |
Males <40 or Females <50 | 2.57 ± 1.34 | 137.87 ± 79.89 | |||
θFPG (mg/dl) | <100 | 2.16 ± 0.91 | <0.001 | 142.90 ± 71.17 | <0.001 |
≥100 | 3.22 ± 1.99 | 98.32 ± 54.91 |
ω25(OH)D, 25-hydroxyvitamin D; αWC, waist circumference; βBMI, body mass index; γSBP, systolic blood pressure; δDBP, diastolic blood pressure; εTC, total cholesterol; ζTGs, triglycerides; ηHDL-C, HDL-cholesterol; θFPG, fasting plasma glucose; µHOMA-IR, homeostasis model assessment of insulin resistance; ψHOMA-B, homeostasis model assessment of beta cell function; §Insulin, fasting insulin.